Short Interest in Aptevo Therapeutics Inc. (NASDAQ:APVO) Grows By 100.7%

Aptevo Therapeutics Inc. (NASDAQ:APVO) saw a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 120,600 shares, a growth of 100.7% from the February 28th total of 60,100 shares. Based on an average trading volume of 65,900 shares, the days-to-cover ratio is currently 1.8 days. Currently, 8.3% of the company’s shares are sold short.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded Aptevo Therapeutics to a “sell” rating in a research report on Saturday, March 15th.

Aptevo Therapeutics Stock Performance

Shares of APVO stock opened at $1.12 on Friday. The company’s 50-day simple moving average is $3.32 and its two-hundred day simple moving average is $140.80. Aptevo Therapeutics has a one year low of $1.12 and a one year high of $180.19.

Aptevo Therapeutics Company Profile

Aptevo Therapeutics Inc, a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. It develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells.